Welcome to our dedicated page for Waters news (Ticker: WAT), a resource for investors and traders seeking the latest updates and insights on Waters stock.
Waters Corporation (NYSE: WAT), a global leader in analytical instrumentation and laboratory technologies, provides critical solutions for pharmaceutical development, food safety testing, and environmental monitoring. This dedicated news hub aggregates official announcements, financial disclosures, and strategic updates directly impacting the company's market position and technological advancements.
Investors and industry professionals will find curated updates including quarterly earnings reports, product innovation announcements, executive leadership changes, and regulatory developments. Our repository ensures timely access to filings, partnership agreements, and scientific breakthroughs related to Waters' chromatography systems, mass spectrometry platforms, and thermal analysis instruments.
Key content categories include financial performance updates, new product launches, research collaborations, and operational expansions. Bookmark this page to monitor developments affecting Waters' role in life sciences R&D, quality assurance protocols, and laboratory informatics solutions across 100+ countries.
Waters Corporation (NYSE:WAT) will announce its Q1 2023 financial results on May 9, 2023, at 8:00 a.m. Eastern Time. A live webcast will be accessible through the company’s investor relations website, with a replay available until May 23, 2023. Waters Corporation has a rich history of over 60 years in analytical instruments, including chromatography and mass spectrometry, and operates in more than 35 countries with over 8,200 employees globally.
Waters Corporation (NYSE:WAT) has launched the Xevo TQ Absolute IVD System, enhancing its MassTrak IVD portfolio. This state-of-the-art system is the most sensitive benchtop tandem quadrupole mass spectrometer for clinical applications, boasting up to five times the sensitivity of its peers. It features a 45% smaller design and consumes 50% less nitrogen gas and electricity, making it environmentally sustainable. The Xevo TQ Absolute IVD allows laboratories to analyze trace-level analytes in smaller samples, thereby expanding testing capabilities for less-invasive assays. The system aims to improve patient care through advanced diagnostic options.
Waters Corporation (NYSE:WAT) has appointed Richard Fearon to its Board of Directors, effective March 27, 2023. Fearon, former Vice Chairman and Chief Financial Officer of Eaton Corporation, is expected to bring financial expertise and strategic development skills to enhance Waters' growth plan. CEO Udit Batra noted that Fearon's leadership experience will strengthen Waters' competitive position. This change follows the retirement of Edward Conard, who has served on the board since 1994, contributing to an 80-fold stock increase over nearly 30 years. The board will now consist of nine members, with three new appointees over the past year.
FAQ
What is the current stock price of Waters (WAT)?
What is the market cap of Waters (WAT)?
